Clinical trials

201

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluation of the Pathobiology of CALR-mutated MPN Cells

The purpose of this study is to understand why there is a greater risk of thrombosis in patients who have the JAK2 mutation as compared to those with CALR mutations.

Participants needed: 35
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Wake Forest University Health SciencesUpdated: Jul 13, 2026Locations: 2
Eligibility criteria

Written (or electronic) informed consent and HIPAA authorization for release of... [+3]

Status: Recruiting

Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54

Low-dose CT Screening has been shown in two large trials in the United States (NLST) and Europe (NELSON) to increase overall survival in subjects 55 years of age and older with a strong smoking history. Unfortunately, in both North Carolina (NC) and South Carolina (SC), subjects are found to have the above referenced smoking history prior to reaching the minimum age in these studies. This study is aimed at decreasing the minimum age of screening in a high-risk population.

Participants needed: 1,160
Trial details
Age: 40-54Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jul 13, 2026Locations: 1
Eligibility criteria

Written informed consent and HIPAA authorization for release of personal health... [+4]

Known diagnosis of lung cancer in the past 5 years. [+2]

Status: Recruiting

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

The purpose of this study is to identify multiple myeloma in the precancerous MGUS stage in order to reduce the risk of delayed diagnosis of multiple myeloma, decrease morbidity related to multiple myeloma at progression, and improve long term outcomes.

Participants needed: 1,665
Trial details
Age: 30+Biological sex: AllType: ObservationalSponsor: Wake Forest University Health SciencesUpdated: Jul 13, 2026Locations: 1
Eligibility criteria

Age 30 years or older at the time of consent [+4]

Self-reported history of MGUS, SMM, MM, AL amyloidosis, plasma cell leukemia, so... [+3]

Status: Recruiting

Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery

The goal of this clinical trial is to determine whether accelerated radiotherapy (involving 6 treatments per week) is better than standard radiotherapy (involving 5 treatments per week) at treating cancer of the head and neck when initiated more than 6 weeks after surgery.

Participants needed: 75
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jul 13, 2026Locations: 3
Eligibility criteria

Pathologically confirmed head and neck squamous cell carcinoma of the oral cavit... [+7]

Recurrent head and neck cancer that has recurred after prior courses of definiti... [+7]

Status: Recruiting

Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy

This study will examine the influence of donor and recipient pharmacogenetics (PG), drug pharmacokinetics (PK), and T cell phenotypes and how it may permit a tailored dosing strategy to improve the therapeutic index of post-transplant cyclophosphamide (PTCy) and optimize the graft versus tumor effect, while minimizing acute and chronic graft versus host disease (GVHD).

Participants needed: 120
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Wake Forest University Health SciencesUpdated: Jul 13, 2026Locations: 1
Eligibility criteria

Informed consent and HIPAA authorization for release of personal health informat... [+4]

Recipient only (applies only to haplo-identical and MRD HCT recipients; not requ... [+2]

Status: Recruiting

Pre-malignant States to Hematologic Malignancies in Firefighters

The purpose of the study is to evaluate if firefighter exposure to hazardous compounds will increase the incidence of premalignant hematological states which subsequently increases the risk of the development of hematologic malignancies, and potentially other pathophysiological consequences.

Participants needed: 300
Trial details
Age: 40-49Biological sex: AllType: ObservationalSponsor: Wake Forest University Health SciencesUpdated: Jul 13, 2026Locations: 1
Eligibility criteria

Written informed consent and HIPAA authorization for release of personal health... [+3]

Status: Recruiting

R.E.C.K vs Exparel in Robotic Nephrectomy

The purpose of the study is to evaluate the efficacy of R.E.C.K (ropivacaine epinephrine clonidine ketorolac) vs Exparel during robotic partial and radical nephrectomy in a single institution, prospective, randomized trial. The study will evaluate post operative Numerical Rating Score (NRS) pain scores, post operative pain medication intake (opioids and over-the-counter pain medicines) and length of stay across the two patient cohorts. The findings will help to inform whether the increased cost of Exparel when compared to R.E.C.K is justified.

Participants needed: 170
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jul 13, 2026Locations: 1
Eligibility criteria

Ability to understand and willingness to sign an IRB-approved informed consent [+2]

Determined not to be a candidate to receive R.E.C.K or Exparel per the enrolling... [+4]

Status: Recruiting

Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway

The study purpose is to gain a better understanding of the needs of adults aged 65 and older while they are receiving chemotherapy by measuring their resilience and tailor care plans based on their individual needs.

Participants needed: 32
Trial details
Age: 65+Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jul 2, 2026Locations: 2
Eligibility criteria

Ability to understand and willingness to sign an IRB-approved informed consent [+5]

Documented physical or psychological comorbidity that would limit participant's... [+2]

Status: Recruiting

Physician Engagement in EMS Transport Refusal Rates

The primary goal of this study is to find out if patients who speak with an EMS physician over the phone are less likely to refuse care compare to patients who do not speak with an EMS physician.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jul 1, 2026Locations: 1
Eligibility criteria

Patients <18 years old. [+3]

Status: Not yet recruiting

Pharmacogenomic Testing in Pediatric Hematology/Oncology Patients

Pharmacogenomic (PGx) testing involves analyzing variants of genes associated with drug metabolism, transport and medication targets. PGx testing uses an individual's genetic factors, such as single nucleotide polymorphisms (SNPs), to personalize therapy or dose a selection of medications. PGx testing has traditionally been used to test single genes, but there are now platforms allowing a panel of genes to be tested at once. To date there has not been a comprehensive screening of pediatric oncology patients to determine the prevalence of genetic variants that may affect anticancer therapy and supportive care medications. This study would allow us to summarize the frequency of clinically relevant gene-drug interactions and actionable genetic polymorphisms in pediatric oncology patients.

Participants needed: 130
Trial details
Age: Up to 26Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jul 2, 2026Locations: 1
Eligibility criteria

Written informed consent and HIPAA authorization for release of personal health... [+2]

Anti-cancer therapy has already been initiated. Note: Enrollment after initiatio... [+2]

Status: Recruiting

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

This study is a prospective evaluation of systemic, intravenous high-dose methotrexate (HD-MTX, 8 g/m2) in patients with triple negative, HER2-positive, and hormone refractory breast cancer with leptomeningeal metastasis (LMD) with or without brain parenchymal involvement.

Participants needed: 16
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jul 2, 2026Locations: 3
Eligibility criteria

Adults (male and female) age >18 [+5]

Prior allergy or adverse reaction to methotrexate [+13]

Status: Not yet recruiting

Mindfulness in Nonflaccid Facial Paralysis

The purpose of this study is to learn more about how mindfulness techniques can help reduce anxiety, depression and body image disturbance as well as improve synkinesis in individuals with non-flaccid facial paralysis.

Participants needed: 24
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jun 30, 2026Locations: 1
Eligibility criteria

Received treatments such as botox or physical therapy for facial paralysis [+1]

Status: Recruiting

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

This study evaluates how adolescent and young adults with cancer in the U.S. and their loved ones respond to questions that will later be used with people who may have cancer and other chronic health conditions

Participants needed: 3,000
Trial details
Age: 15+Biological sex: AllType: ObservationalSponsor: Wake Forest University Health SciencesUpdated: Jun 30, 2026Locations: 1
Eligibility criteria

Young adults between the ages of 15 to 39 years; [+4]

Diagnosed with basal cell skin cancer; or [+9]

Status: Not yet recruiting

Narrative Medicine Effects on Burnout and Stress

A rising area of interest over the past several years has been on the issue of physician burnout. Burnout can be defined as a chronic occupational stress response characterized by multi-dimensional exhaustion and diminished sense of fulfillment in one's personal and professional life. Regarding the effects of emotional, occupational and physical stress on job satisfaction, standard of care and staff retention, it is important to determine meaningful methods to alleviate and prevent burnout among healthcare professionals.

Participants needed: 60
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jun 29, 2026Locations: 1
Eligibility criteria

Study participants must be current faculty at Atrium Health Wake Forest Baptist...

Faculty who are not currently working at AHWFB may be excluded

Status: Recruiting

Enhancing Slow Wave Sleep in Depression

The goal of this pilot study is to determine if non-invasive brain stimulation during sleep can increase deep sleep in adults with depression. It will also determine if increased deep sleep improves cognitive performance and mood ratings. Participants will be asked to wear a non-invasive device that records their brain activity and delivers transcranial electrical stimulation during sleep. Participants will also wear an actigraphy watch that measures activity levels throughout the study. In addition, participants will complete several cognitive assessments and mood and sleep questionnaires throughout the study.

Participants needed: 12
Trial details
Age: 40-80Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jun 29, 2026Locations: 1
Eligibility criteria

Ability to complete overnight sleep study including placement of EEG leads [+3]

Previous adverse reaction to transcranial electrical stimulation [+12]

Status: Recruiting

Randomized Control Trial, Cryoablation as an Adjunct to Surgical Stabilization of Rib Fractures

To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of Surgical Stabilization of Rib Fractures (SSRF) without cryoablation

Participants needed: 80
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jun 29, 2026Locations: 1
Eligibility criteria

The patient is admitted to the trauma service. [+4]

Age < 18 years or ≥ 80 years [+11]

Status: Recruiting

Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm

The purpose of this research is to learn about how salt in the diet influences blood pressure in young adults who were born prematurely.

Participants needed: 120
Trial details
Phase: Early Phase 1Age: 22-33Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jun 29, 2026Locations: 1
Eligibility criteria

Singleton birth [+2]

Twin birth [+8]

Status: Not yet recruiting

Breast-milk Enema Administration to Stimulate Passage of Meconium

Lack of passage of meconium in preterm infants delays feeding advancement and may represent a risk factor for necrotizing enterocolitis (NEC) and spontaneous intestinal perforation (SIP). Usual management of meconium impaction has included glycerin suppositories and normal saline enemas. Various methods are used in routine neonatal care to promote meconium evacuation; however, there is no consensus on the agents used and the frequency of applications

Participants needed: 20
Trial details
Phase: Phase 1Age: 23-28Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jun 30, 2026Locations: 1
Eligibility criteria

Preterm infants born at >23 and <28 weeks' gestational age born at Atrium Health... [+3]

Infants with Necrotizing Enterocolitis (NEC) ≥ stage II [+5]

Status: Not yet recruiting

Amnion Membrane Powder Mohs Study

The purpose of this research study is to test the safety of the amnion membrane powder to see if it improves wound healing in patients undergoing Mohs surgery on the scalp.

Participants needed: 20
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jul 1, 2026Locations: 1
Eligibility criteria

The subject requires Mohs surgery on the scalp, with the resulting wound extendi... [+5]

The subject's wound site is smaller than 4cm2. [+16]

Status: Not yet recruiting

Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct

The purpose of this research study is to find out if autologous "neo-bladder" construct for the treatment of fibrotic and/or contracted bladder can improve bladder compliance and be safe long term. The neo-bladder is like a reservoir or pouch that will be surgically attached to the bladder to assist with urine collection.

Participants needed: 10
Trial details
Phase: Phase 2Age: 18-60Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jun 30, 2026Locations: 1
Eligibility criteria

Subjects with small contracted and/or fibrotic non-neurogenic bladder. [+35]

Status: Not yet recruiting

RIsE Stroke Mobility Study

This study is designed to better understand how patients with severe stroke move during their hospital stay. It will track their activity using a small wearable device (activPAL) along with standard mobility information already collected in clinical care. The goal is to learn what typical movement patterns look like early after a stroke and how well patients meet mobility goals while in the hospital. What is learned from this study may allow determination of how treatment for stroke patients may be improved to improve patient long-term mobility.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jun 25, 2026Locations: 1
Eligibility criteria

Adults aged 18 years and older [+4]

Current or expected End-of-life discussions [+7]

Status: Not yet recruiting

MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation

The purpose of this research study is to find out if the use of magnesium in addition to Metoprolol, a rate controlling medication that you would be offered in the Emergency Department today unrelated to this study, will help reduce your high heart rate (rapid ventricular response).

Participants needed: 196
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jun 29, 2026Locations: 1
Eligibility criteria

Age > 18 years or older [+4]

Hemodynamically unstable patients (SBP <90, MAP <65) [+9]

Status: Not yet recruiting

Azithromycin for Cerclage Prophylaxis

The primary goal is to assess the effectiveness in pregnancy prolongation utilizing azithromycin at the time of transvaginal cervical cerclage placement.

Participants needed: 80
Trial details
Phase: Phase 4Age: 18+Biological sex: FemaleType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jun 25, 2026Locations: 2
Eligibility criteria

Singleton gestation at 16+0 to 23+6 weeks of gestational age at the time of enro... [+2]

Evidence of active infection or chorioamnionitis at presentation [+7]

Status: Not yet recruiting

Auditory Stimulation for Insomnia and Depression

The goal of this clinical trial is to determine if alpha phase-locked auditory stimulation can improve sleep in people with insomnia and depression. The main goals of the pilot study are the following: Determine whether alpha phase-locked auditory stimulation (active stimulation) improves objective and subjective sleep in individuals with insomnia and depression. The study team hypothesizes that active auditory stimulation will reduce objective and subjective sleep onset latency (SL) and wake after sleep onset (WASO) compared to a sham stimulation. Participants will: * Wear Elemind Neuromod headband nightly for 4 weeks (1 week baseline, 1 week active/sham stimulation, 1 week washout, and 1 week opposite condition - active/sham stimulation) * Wear actigraphy watch for duration of the study * Complete questionnaires regarding their sleep, mood, and satisfaction with the device

Participants needed: 25
Trial details
Age: 20-50Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jun 26, 2026Locations: 1
Eligibility criteria

Ability to complete overnight EEG study including placement of EEG leads [+4]

Presence of severe, untreated sleep apnea [+7]

Status: Not yet recruiting

The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma

The goal of this study is to learn whether children, adolescents, and young adults with newly diagnosed high-grade osteosarcoma can be safely discharged from the hospital at slightly higher methotrexate blood levels after receiving standard high-dose methotrexate chemotherapy. Participants are 22 years old or younger and are receiving standard MAP (high-dose methotrexate with doxorubicin and cisplatin) chemotherapy as part of their routine cancer treatment. The main questions this study aims to answer are: * Is hospital discharge at higher methotrexate levels safe, based on side effects or hospital re-admission within 7 days? * Can patient-derived osteosarcoma tumor organoids be successfully generated across multiple centers? Researchers will compare safety outcomes and hospital length of stay to historical patient data discharged at lower methotrexate levels. Participants will receive standard chemotherapy, meet study-defined discharge criteria, be monitored for side effects, and have the option to provide tumor and blood samples for future research.

Participants needed: 46
Trial details
Phase: Phase 2Age: 7-22Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jun 25, 2026Locations: 8
Eligibility criteria

Suspected diagnosis of high-grade osteosarcoma based on clinical and radiographi... [+14]

Female participants who are pregnant and/or lactating and breast feeding their i... [+1]